Exposure to Human Immunodeficiency Virus (Event)
Conditions
Keywords
PEP, nPEP, Post Exposure Prophylaxis, non occupational exposure to HIV
Brief summary
Observational study looking at barriers to care for individuals seeking care, Post Exposure Prophylaxis (PEP) after an actual or perceived exposure to HIV. Following PEP treatment subjects will be asked about there intent to transition to Pre-Exposure Prophylaxis (PrEP) and surveyed about barriers to care or perceptions of care
Detailed description
The primary objective of this study is to assess the rate of engagement in a PEP to PrEP HIV provider network for those patients presenting following a non-occupational HIV exposure. The development of a referral network and intensive clinical follow up of PEP patients will result in more patients appropriately initiating PEP, being referred to appropriate follow up, and post exposure transition and maintaining on PrEP (if indicated) at completion of the PEP medications.
Interventions
subjects will be treated according to current Department of Health and Human Services (DHHS) Center for Disease control and prevention (CDC), Society for Healthcare Epidemiology of American (SHEA guidelines for nPEP
Sponsors
Study design
Eligibility
Inclusion criteria
* Actual or perceived non-occupational exposure to HIV, by self report, within 72 hours of enrollment and referred for care * able and willing to provide informed consent * available for 12 months of post expoure follow-up Southern Nevada Ryan White defined service area
Exclusion criteria
* HIV+ at time of screeing via 4th genderation (Antibody/Antigen) testing * Current PEP and/or PrEP product condrainidications as listed in the medication product insert.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| rate of engagement | from enrollment to day 90 | Assess the rate of engagement in a PEP to PrEP HIV prevention provider network for those patients presenting following a non-occupational HIV exposure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| characteristics | from enrollment through end of study for all participants | Describe the characteristics of patients successfully engaging in HIV prevention via a patient collected survey using a qualtric survey. |
| barriers | from enrollment through end of study for all participants | Identify and assess barriers to access to HIV prevention care including PEP in the period immediately following HIV exposure from a patient collected survey using a qualtric survey tool |
| Network characteristics | from enrollment through end of study for all participants | Analyze the network characteristics that faciliate engagement in HIV prevention services from a patient collected survey using a qualtric survey tool |
| transition barriers | from enrollment through end of study for all participants | Determine and assess to transitioning from PEP to PrEP from a patient collected survey using a qualtric survey tool |
| Retention | from enrollment through end of study for all participants | Compare and contrast the barriers to access and ongoing retention to PrEP from a patient collected survey using a qualtric survey tool. |
Countries
United States